2024
-
View from the Trenches panelists share thoughts on translating SABCS® presentations into practice
Experts wrapped up the 2024 San Antonio Breast Cancer Symposium® by discussing updates from the week that may have an immediate impact for patients and physicians.
-
Year in Review session summarizes important breast cancer takeaways from 2024
Neil Vasan, MD, PhD; Pedram Razavi, MD, PhD; Janice Tsang, MBBS, MRCP, FRCP; and Michael A. Danso, MD, highlighted recent developments across breast cancer research and care.
-
Special Session explores considerations behind breast cancer drug approvals, trials
Panelists discussed recent U.S. Food and Drug Administration approvals, plus the importance of monitoring ovarian toxicity in breast cancer clinical trials.
-
Experts review approaches to reducing obesity-related risk for breast cancer
Presenters focused on the mechanisms linking obesity to breast cancer risk and discussed modifiable factors such as body weight, dietary patterns, and physical activity.
-
General Session 3 includes results from ZEST study, analysis from TAILORx trial
Nicholas Turner, MD, PhD; Nan Chen, MD; and Pedram Razavi, MD, PhD, were among eight experts reporting results Friday during the third and final General Session of the 2024 San Antonio Breast Cancer Symposium®.
-
Plenary lecturer: Human Breast Cell Atlas charts pathway from healthy tissue to cancer
Walid Khaled, PhD, on Friday discussed work to draw a map of how the breast changes during tumorigenesis and progression.
-
AACR Distinguished Lectureship recipient offers insight into invasive lobular carcinoma research
Steffi Oesterreich, PhD, on Thursday shared highlights from her seminal fundamental and translational research on invasive lobular carcinoma.
-
Special Session highlights lifestyle factors during breast cancer treatment
A panel of experts on Tuesday offered guidance for patients and clinicians who have questions about the interplay of treatment and nutrition, physical activity, and sexual health.
-
Plenary lecture emphasizes interrelated factors behind disparities in breast cancer research, care
Melissa B. Davis, PhD, on Thursday addressed the challenges of unraveling social versus biological drivers of racial disparities in cancer outcomes.
-
AACR Outstanding Investigator shares work on integrative breast cancer subtypes
Christina Curtis, PhD, MSc, on Wednesday discussed processes that drive cancer progression across various disease stages and molecular subtypes.